SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 374 filers reported holding SHOCKWAVE MED INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,902 | -56.2% | 1,220 | -65.3% | 0.01% | -8.3% |
| Q2 2023 | $554,736 | +1313.3% | 3,512 | +172.9% | 0.01% | +500.0% |
| Q1 2023 | $39,251 | +52234.7% | 1,287 | -29.4% | 0.00% | 0.0% |
| Q4 2022 | $75 | -99.9% | 1,822 | +18.6% | 0.00% | 0.0% |
| Q3 2022 | $64,000 | +33.3% | 1,536 | +15.1% | 0.00% | 0.0% |
| Q2 2022 | $48,000 | -46.7% | 1,335 | -46.7% | 0.00% | +100.0% |
| Q1 2022 | $90,000 | -56.3% | 2,505 | +117.1% | 0.00% | -75.0% |
| Q4 2021 | $206,000 | -13.1% | 1,154 | +0.3% | 0.00% | -20.0% |
| Q3 2021 | $237,000 | +5.8% | 1,151 | -3.3% | 0.01% | 0.0% |
| Q2 2021 | $224,000 | +42.7% | 1,190 | -0.4% | 0.01% | +66.7% |
| Q1 2021 | $157,000 | +44.0% | 1,195 | +12.7% | 0.00% | -25.0% |
| Q4 2020 | $109,000 | +5350.0% | 1,060 | +4140.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |